about
Acute coronary syndromes in human immunodeficiency virus patients: a meta-analysis investigating adverse event rates and the role of antiretroviral therapyIdiopathic thrombocytopenic purpura and percutaneous coronary stenting: a dangerous duo?Pressure ulcer: an unreported complication of the Safeguard® hemostasis device. No need to crack under pressure.Drug-eluting stent implantation in primary angioplasty of an anomalous left main coronary artery: diagnostic and technical considerations.International collaborative systematic review of controlled clinical trials on pharmacologic treatments for acute pericarditis and its recurrences.TIMI, GRACE and alternative risk scores in Acute Coronary Syndromes: a meta-analysis of 40 derivation studies on 216,552 patients and of 42 validation studies on 31,625 patients.Prevalence and non-invasive predictors of left main or three-vessel coronary disease: evidence from a collaborative international meta-analysis including 22 740 patients.Remote ischaemic preconditioning in coronary artery bypass surgery: a meta-analysis.Use and misuse of multivariable approaches in interventional cardiology studies on drug-eluting stents: a systematic review.Percutaneous coronary intervention in nonagenarian: a meta-analysis of observational studies.Update on dedicated bifurcation stents.A long-term comparison of drug-eluting versus bare metal stents for the percutaneous treatment of coronary bifurcation lesions.Meta-analysis of coronary CT angiography in the emergency department: reply.Very long-term results comparing a simple versus a complex stenting strategy in the treatment of coronary bifurcation lesions.Appraising the impact of left ventricular ejection fraction on outcomes of percutaneous drug-eluting stenting for unprotected left main disease: insights from a multicenter registry of 975 patients.Impact of routine angiographic follow-up after percutaneous coronary drug-eluting stenting for unprotected left main disease: the Turin Registry.Impact of diabetes mellitus on early and long-term results of percutaneous drug-eluting stent implantation for unprotected left main coronary disease.Diffuse coronary disease: short- and long-term outcome after percutaneous coronary intervention.Current management of unprotected left main coronary artery disease: run-in survey of the RITMO (Registro Italiano sul Trattamento del tronco coMune non protettO) study.Percutaneous coronary intervention on left main coronary artery trifurcation.Longest available clinical outcomes after drug-eluting stent implantation for unprotected left main coronary artery disease: the DELFT (Drug Eluting stent for LeFT main) Registry.Retrograde septal approach for a challenging chronic total occlusion of the right coronary artery.Intra-arterial lidocaine versus saline to reduce peri-procedural discomfort in patients undergoing percutaneous trans-radial or trans-ulnar coronary procedures.Short- and long-term outcomes of percutaneous coronary interventions in patients with severe left ventricular dysfunction.Paclitaxel-eluting stents for the treatment of complex coronary lesions: immediate and 12-month results.Long-term clinical and angiographic outcomes of treatment of unprotected left main coronary artery stenosis with sirolimus-eluting stents.Favorable long-term outcome after drug-eluting stent implantation in nonbifurcation lesions that involve unprotected left main coronary artery: a multicenter registry.Iatrogenic left internal mammary artery-coronary vein anastomosis treated with covered stent deployment via retrograde percutaneous coronary sinus approach.Gender differences in patients undergoing TAVI: a multicentre study.Transjugular tricuspid valve-in-valve implantation.Immediate and medium-term outcomes following the treatment of very long (> or =50 mm) chronic total coronary artery occlusions.Coronary computed tomographic angiography for detection of coronary artery disease in patients presenting to the emergency department with chest pain: a meta-analysis of randomized clinical trials.Postpartum valve thrombosis: a happy ending thriller.Cre8™ coronary stent: preclinical in vivo assessment of a new generation polymer-free DES with Amphilimus™ formulation.In vivo coronary plaque histology in patients with stable and acute coronary syndromes30days and midterm outcomes of patients undergoing percutaneous replacement of aortic valve according to their renal function: A multicenter studyInaccuracy of available surgical risk scores to predict outcomes after transcatheter aortic valve replacementChoosing the best first line oral drug agent in patients with pulmonary hypertension: Evidence from a network meta-analysisDrugs for attention deficit–hyperactivity disorder do not increase the mid-term risk of sudden death in children: A meta-analysis of observational studiesAtherosclerotic coronary plaque regression and the risk of adverse cardiovascular events: A meta-regression of randomized clinical trials
P50
Q27008328-1D94B043-60D8-472A-998C-0D5DAF70B477Q28221551-83B880F5-9629-4CC5-8182-B5EB4526399BQ35252875-8440F692-1015-4B3F-B298-865B8F95560AQ35956089-83890648-345B-4DAC-A97B-D399C4991FDAQ37799119-73DC2769-6083-4571-B090-6ED6D381AD3FQ37977758-9CB3C80D-B0C3-4904-A9F3-73441BD897D2Q38012933-63FBD271-4BFA-438E-8C78-4E18AFA8E898Q38033139-9EAA7552-3D8C-423A-82C9-113E157C6697Q38033691-B4FC7E9D-3BD1-4AF2-8FB3-E06E320CFFAFQ38113649-B99D712C-0E4D-473D-B9F9-E26F1E348819Q39986181-DAA401AB-35D1-451C-A9C4-165D38DB300BQ43199508-28CE9273-4137-4F3F-829A-DD9398B21D93Q43521281-B6CA13A5-4D5C-46B3-B491-21770C92DB05Q43976063-18DA9025-8716-4EEC-B7E2-28F351E128E8Q44695712-9FCF32F1-AAAA-4835-ADF7-DB32CA6E5014Q44836472-31222C57-75B8-46AF-AAF1-B1C3F6B25793Q45005337-5B2611F9-D87C-4D2C-9CB5-9E4D1131BAFFQ45807421-2517F783-22BD-46E5-9335-5189FC1D195CQ46050202-F702B824-8572-4560-AB3B-B9DFE980BD30Q47436848-9C055427-EAAE-4ED4-9749-C0294D7E98BAQ47660601-0D6EAFD7-7A1F-419F-87D5-8A5BF06C237BQ47978694-C66AB210-CBF9-48B4-BE49-0A1A03C6F846Q48275897-C96234DD-8BAE-4D95-BCA0-4799CB664860Q48377347-E7EFC83A-381D-4866-AF27-5A8DCB8C5F6EQ50947073-930EF6C0-3F8B-4F8E-9792-FC15473A01DCQ50949297-17DCC04C-8527-409F-AE32-C62556A9A5CFQ50976594-237B58AA-4A61-4DA0-BE35-6ED4565EF236Q51119328-37BF4C9E-6680-4435-8834-18F1D2A032A6Q51222700-50E4CD71-6998-4CAC-AB91-5F77D27F98D6Q51238469-45A228CB-3FF1-471B-BDD5-85025609BD2AQ51727307-AB78607E-0F97-450F-B447-530DAD013385Q53129467-FDD40BCD-E975-40B7-ADB6-B0E7BE3F4A08Q53162372-A4DD4D4F-BFD5-4F6D-926F-F753B8F2E3D6Q53202016-F55A4F3D-A4AB-4DE7-A5D6-ED10EA170476Q56986756-3E6EE3C5-660C-4622-A25C-91A447A8CFF2Q57730838-3E31F3AB-5964-4599-A2F4-FAB37C56FB31Q57730847-38A02851-BC14-49BB-A7F8-4088F448B981Q57730851-E07C8E67-4755-4CB1-833B-731D8AA682D4Q57730858-E4E6B61E-C7F5-4B0F-AB4F-03673022191DQ57730866-2C268474-561B-425F-8ED5-D55391503F9D
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Claudio Moretti
@ast
Claudio Moretti
@en
Claudio Moretti
@es
Claudio Moretti
@nl
type
label
Claudio Moretti
@ast
Claudio Moretti
@en
Claudio Moretti
@es
Claudio Moretti
@nl
prefLabel
Claudio Moretti
@ast
Claudio Moretti
@en
Claudio Moretti
@es
Claudio Moretti
@nl
P106
P21
P31
P496
0000-0002-4475-7289